Skip to content

Effects of Intermittent Theta Burst Stimulation on Upper Limb Motor Function in Stroke Patients

Effects of Intermittent Theta Burst Stimulation on Upper Limb Motor Function in Stroke Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097636
Enrollment
Unknown
Registered
2025-02-23
Start date
2025-02-24
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:Intermittent Theta burst stimulation combined with conventional rehabilitation therapy
Control group:5Hz repetitive transcranial magnetic stimulation combined with conventional physical therapy

Sponsors

Beijing Xiaotangshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 Meet the diagnostic criteria for stroke issued by the Chinese Society of Neurology, Chinese Medical Association, and be diagnosed as subcortical hemorrhagic stroke or subcortical ischemic stroke by head CT and/or MRI; 2 The injured hemisphere was unilateral, with unilateral limb motor dysfunction; 3 The onset of the first episode, the course of disease ranged from 15 days to 3 months; 4 Age 30 <= age <=75 years old; 5 Brunnstrom stage of upper limbs and hands was ?-IV; 6 The patient was right-handed before the onset. 7 clear consciousness, able to cooperate with physical examination, and without severe cognitive impairment; 8 All patients volunteered to participate in the iTBS or HF-rTMS treatment and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1 metallic foreign body in the head, with implantable pulse stimulation generator or drug pump, cochlear implant; 2 people at high risk of noise-induced hearing loss (including those treated with ototoxic drugs and those exposed to solvents), people with hyperacusis symptoms; 3 Pregnant patients; 4 severe or recent heart disease; 5 history of epilepsy, severe heart, lung, liver, kidney and other important organ failure, and intracranial hypertension; 6 severe cognitive, communication disorders, emotional disorders, irritability and other inability to cooperate; 7 those who received iTBS or HF-rTMS within 3 months before the study; 8 Skull or hand defects; 9 The investigator considered it inappropriate to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment of Upper Extremity;Upper limb muscle strength and tension;Wolf Motor Function Test;Stroke Impact Scale -16;

Secondary

MeasureTime frame
Motor Evoked Potential;Central Motor Conduction Time;Resting Motor Threshold;Current Perception Threshold;Semmes-Weinstein Monofilament;Action Research Arm Test score;

Countries

China

Contacts

Public ContactLiang Wu

Beijing Xiaotangshan Hospital

1972wuliang@sina.com+86 152 1087 8101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026